Clinical trial
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in…
NCT00458848 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Completed
Key facts
| NCT number | NCT00458848 |
|---|---|
| Title | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia |
| Official title | Phase II Study of Adult Acute Lymphoblastic Leukaemia (ALL): Imatinib in Combination With Chemotherapy in Ph+ Patients, and Post-remissional Treatment Intensification in High-risk Ph- Patients, With Minimal Residual Disease Monitoring. |
| Acronym | LAL0904 |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | asparaginase, daunorubicin hydrochloride, etoposide, idarubicin, imatinib mesylate, mercaptopurine, methotrexate, methylprednisolone, mitoxantrone hydrochloride, prednisone and 5 more |
| Enrollment | 470 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2014 |
| Completion | Mar 1, 2014 |
| First posted | Apr 11, 2007 |
| Last update posted | Feb 15, 2019 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: